What is "immudex"

Immudex is a Danish Reagents and Diagnostics company established in 2009. The company is operating from offices located in Copenhagen, Denmark, and in Fairfax, Virginia. Immudex specializes in the production of MHC Dextramers. MHC Dextramers are chemical reagents that are designed to detect antigen-specific T cells.

All Immudex products, whether on the marked or in development, are based on its proprietary MHC Dextramer technology. The use of MHC Dextramers offers a new method to accurately detect and quantify antigen-specific CD8+ T cells.

While some of the technology is currently only sold for Research use only (RUO), clinical applications are being actively pursued. Currently, Immudex has several development projects for clinically applicable MHC Dextramers. Even so, the first MHC Dextramers clinical reagent has been developed and approved for clinical in vitro diagnostics in Europe. Namely the CE-marked kit for enumeration of cytomegalovirus-specific T cells. Immudex primarily focuses on the identification of producing large quantities of CD8+ T cells by the means of MHC class I molecules. Even so, the research and development into the application of MHC class II Dextramers might expand the technology.